The UK has approved a COVID vaccine - here's what scientists now want to know.

@article{Ledford2020TheUH,
  title={The UK has approved a COVID vaccine - here's what scientists now want to know.},
  author={Heidi Ledford and David Cyranoski and Richard van Noorden},
  journal={Nature},
  year={2020}
}

How to Face the Advent of SARS-CoV-2 Vaccination in IBD Patients: Another Task for Gastroenterologists

TLDR
The factors associated with the acceptability of SARS-CoV-2 vaccination are dissected, describing the possible strategies that gastroenterologist should adopt to reach the highest rate of vaccinations in IBD patients.

COVID-19 Vaccines and the Skin

Evaluation of Side Effects Associated with COVID-19 Vaccines in Saudi Arabia

TLDR
Side effects that are reported post Oxford-AstraZeneca and Pfizer-BioNTech vaccines among study participants are not different from those that were reported in the clinical trials, indicating safe profiles for both vaccines.

Conscience and Vaccines: Lessons from Babylon 5 and COVID-19

  • Michal Pruski
  • Medicine
    The New bioethics : a multidisciplinary journal of biotechnology and the body
  • 2021
TLDR
Some aspects of the COVID-19 vaccines' development and roll-out are discussed, demonstrating that people (be it patients or clinicians) might object to some vaccines due to reasonable ethics and safety-based concerns rather than due to an anti-vaxxer mind-set.

COVID-19 vaccine: Potential candidates, achievements, and challenges

TLDR
Efficacy, rapid mass production, and long-term immunity as well as acceptance of vaccination by society are the main challenges in developing a safe vaccine against CO VID-19 despite the fact that some vaccines have over 90% efficiency against COVID-19 and are useful in developing immunity.

Meet the Challenges of Mass Vaccination against COVID-19

TLDR
Three guiding principles are proposed and cautionary perspectives on the mass vaccination against COVID-19 are shared to help shape policy-making and the implementation of themass vaccination.

How the clinical research community responded to the COVID-19 pandemic: an analysis of the COVID-19 clinical studies in ClinicalTrials.gov

TLDR
Most COVID-19 clinical studies included both genders and older adults, however, risk factors such as diabetes, hypertension, and pregnancy were under-represented, likely skewing the population that was sampled.

Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile

TLDR
The results suggest that the inactivated SARS-CoV-2 vaccine effectively prevented Covid-19, including severe disease and death, a finding that is consistent with results of phase 2 trials of the vaccine.

How the clinical research community responded to the COVID-19 pandemic: An analysis of the COVID-19 clinical studies in ClinicalTrials.gov

TLDR
A careful examination of the registered CO VID-19 clinical studies can identify the research gaps and inform future COVID-19 trial design towards balanced internal validity and generalizability.
...